BusinessBeiGene Presents Updated Clinical Data on BTK Inhibitor BGB-3111 in Patients with Waldenstrom’s Macroglobulinemia at 9th International Workshop on Waldenstrom’s MacroglobulinemiaBy Nasdaq OMXOct 7, 2016, 1:45 PM UTC
BusinessBeiGene to Host Conference Call on BGB-3111 Data Presentation at IWWM-9By Nasdaq OMXOct 4, 2016, 8:15 PM UTC
